Cargando…

N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.

N-Benzyladriamycin-14-valerate (AD198) is a novel lipophilic anthracycline with greater in vivo antitumour activity than doxorubicin (DOX) in experimental model systems. Using sensitive and progressively DOX-resistant L1210 mouse leukaemia and B16-BL6 mouse melanoma lines, we have determined the cel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ganapathi, R., Grabowski, D., Sweatman, T. W., Seshadri, R., Israel, M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1989
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247277/ https://www.ncbi.nlm.nih.gov/pubmed/2605093

Ejemplares similares

N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma
por: Edwards, Shanique K E, et al.
Publicado: (2013)

Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
por: Kamath, N., et al.
Publicado: (1993)

Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance.
por: Ganapathi, R., et al.
Publicado: (1988)

Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells.
por: Ganapathi, R., et al.
Publicado: (1986)

Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model
por: Christowitz, Claudia, et al.
Publicado: (2019)

Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.
por: Ramu, A., et al.
Publicado: (1984)

Ultrasound-Assisted Esterification of Valeric Acid to Alkyl Valerates Promoted by Biosilicified Lipases
por: Cebrián-García, Soledad, et al.
Publicado: (2018)

Brovalol, a New Valeric
Publicado: (1909)

Tuneable Acidity in Fluorinated Al-SBA-15 Materials for the Esterification of Valeric Acid to Alkyl Valerates
por: Blanco-Sánchez, Miguel, et al.
Publicado: (2020)

Valer la pena : México, 1996-2000 /
por: Gelman, Juan, 1930-2014
Publicado: (2001)

Characterization of a doxorubicin-resistant murine melanoma line: studies on cross-resistance and its circumvention.
por: Supino, R., et al.
Publicado: (1986)

Pharmacological sympathetic denervation prevents the development of polycystic ovarian syndrome in rats injected with estradiol valerate
por: Espinoza, Julieta A., et al.
Publicado: (2018)

In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.
por: Ripamonti, M., et al.
Publicado: (1992)

Role of the aclacinomycin A--doxorubicin association in reversal of doxorubicin resistance in K562 tumour cells.
por: Millot, J. M., et al.
Publicado: (1989)

Contraception with estradiol valerate and dienogest: adherence to the method
por: Fruzzetti, Franca, et al.
Publicado: (2019)

Characterisation of a mouse tumour cell line with in vitro derived resistance to verapamil.
por: Twentyman, P. R., et al.
Publicado: (1990)

Estradiol valerate and alcohol intake: dose-response assessments
por: Quirarte, Gina L, et al.
Publicado: (2007)

The Effect of Valeric on Anxiety Severity in Women Undergoing Hysterosalpingography
por: Gharib, Maryam, et al.
Publicado: (2015)

Estradiol Valerate Affects Hematological and Hemorheological Parameters in Rats
por: Barath, Barbara, et al.
Publicado: (2022)

Kinetics of Thermal Degradation of Betamethasone Valerate and Betamethasone Dipropionate in Different Media
por: Khattak, S. U. R., et al.
Publicado: (2012)

Development of drug resistance in a murine mammary tumour.
por: McMillan, T. J., et al.
Publicado: (1985)

Cyclosporin A and doxorubicin-ifosfamide in resistant solid tumours: a phase I and an immunological study.
por: González-Manzano, R., et al.
Publicado: (1995)

Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest
por: Rafie, Sally, et al.
Publicado: (2013)

Estradiol valerate and dienogest: a new approach to oral contraception
por: Kiley, Jessica W, et al.
Publicado: (2011)

Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest
por: Bitzer, Johannes, et al.
Publicado: (2011)

Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamil.
por: Merry, S., et al.
Publicado: (1989)

New perspectives on epigenetic modifications and PARP inhibitor resistance in HR-deficient cancers
por: Bayley, Rachel, et al.
Publicado: (2023)

Stereological study of the effects of letrozole and estradiol valerate treatment on the ovary of rats
por: Noorafshan, Ali, et al.
Publicado: (2013)

A Comparison of Betamethasone Valerate 0.1% Cream Twice Daily Plus Oral Simvastatin Versus Betamethasone Valerate 0.1% Cream Alone in the Treatment of Vitiligo Patients
por: Iraji, Fariba, et al.
Publicado: (2017)

Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression.
por: Nygren, P., et al.
Publicado: (1991)

Short-chain-fatty acid valerate reduces voluntary alcohol intake in male mice
por: Bokoliya, Suresh C, et al.
Publicado: (2023)

Characterisation of Human Tumours
por: Bazill, G. W.
Publicado: (1976)

Modulation of vinblastine cytotoxicity by dilantin (phenytoin) or the protein phosphatase inhibitor okadaic acid involves the potentiation of anti-mitotic effects and induction of apoptosis in human tumour cells.
por: Kawamura, K. I., et al.
Publicado: (1996)

Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016)

Pivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo
por: Lothstein, Leonard, et al.
Publicado: (2020)

Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.
por: Suzuki, S., et al.
Publicado: (1997)

Changes of The Uterine Tissue in Rats with Polycystic Ovary Syndrome Induced by Estradiol Valerate
por: Mirabolghasemi, Ghadire, et al.
Publicado: (2017)

Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis
por: Asad, Farah, et al.
Publicado: (2017)

The Comparative Pharmaco- and Histokinetics of the Therapeutic Dose of Estradiol Valerate and Bromocriptine in Common Quails
por: Nadeem, Muhammad, et al.
Publicado: (2022)

Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
por: Schuurhuis, G. J., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_u9rb99e69l8uktskhklu155v8a